Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$FENC Q2 '26 Earnings Results & Recap Fennec Pharmaceuticals recorded $17.1 million in net product sales for Q2 2026, up 78% year over year, and achieved $2.8 million in non-GAAP adjusted EBITDA for the quarter.

Price since post

Full Details

Advertisement|Remove ads.